Chemistry:Sunobinop

From HandWiki
Revision as of 20:40, 5 February 2024 by Jslovo (talk | contribs) (change)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Short description: Chemical compound
Sunobinop
Sunobinop.svg
Clinical data
Other namesIMB-115
Drug classNociceptin receptor agonist
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
Chemical and physical data
FormulaC26H33N3O3
Molar mass435.568 g·mol−1
3D model (JSmol)

Sunobinop (developmental code name IMB-115) is a nociceptin receptor partial agonist and opioid receptor pan-antagonist.[1] As of March 2022, it is under investigation for the treatment of insomnia, fibromyalgia, and overactive bladder.[1][2]

See also

References

  1. 1.0 1.1 "Sunobinop - Shionogi/Imbrium Therapeutics". AdisInsight. Springer Nature Switzerland AG. https://adisinsight.springer.com/drugs/800035863. 
  2. Harris SC, Kapil RP, Kyle DJ, Whiteside G, "Treatment and prevention of sleep disorders", WO patent application 2018020418, published 2018-02-01, assigned to Purdue Pharma L.P.